Acute diarrhea

Infectious Diseases: Third Edition

Volumn 1, Issue , 2010, Pages 381-388

  Drancourt, Michel ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872149083     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04579-7.00035-6     Document Type: Chapter

References (83)

1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J.L. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757.
2. Hotez P.J., Molyneux D.H., Fenwick A., et al. Control of neglected tropical diseases. N Engl J Med 2007, 357:1018-1027.
3. Imhoff B., Morse D., Shiferaw B., et al. Burden of self-reported acute diarrheal illness in FoodNet surveillance areas, 1998-1999. Clin Infect Dis 2004, 38(Suppl.3):S219-S226.
4. Sandler R.S., Everhart J.E., Donowitz M., et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002, 122:1500-1511.
5. Mead P.S., Slutsker L., Dietz V., et al. Food-related illness and death in the United States. Emerg Infect Dis 1999, 5:607-625.
6. de Wit M.A., Hoogenboom-Verdegaal A.M., Goosen E.S., Sprenger M.J., Borgdorff M.W. A population-based longitudinal study on the incidence and disease burden of gastroenteritis and Campylobacter and Salmonella infection in four regions of The Netherlands. Eur J Epidemiol 2000, 16:713-718.
7. Hedberg C.W., Greenblatt J.F., Matyas B.T., et al. Enteric Disease Investigation Timeline Study Work Group. Timeliness of enteric disease surveillance in 6 US states. Emerg Infect Dis 2008, 14:311-313.
8. Podewils L.J., Zanardi Blevins L., Hagenbuch M., et al. Outbreak of norovirus illness associated with a swimming pool. Epidemiol Infect 2007, 135:827-833.
9. Verhoef L., Depoortere E., Boxman I., et al. Food Borne Viruses in Europe Network. Emergence of new norovirus variants on spring cruise ships and prediction of winter epidemics. Emerg Infect Dis 2008, 14:238-243.
10. Filler G., Ehrich J.H., Strauch E., Beutin L. Acute renal failure in an infant associated with cytotoxic Aeromonas sobria isolated from patient's stool and from aquarium water as suspected source of infection. J Clin Microbiol 2000, 38:469-470.
11. Patel M.M., Widdowson M.A., Glass R.I., Akazawa K., Vinjé J., Parashar U.D. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 2008, 14:1224-1231.
12. Gravel D., Miller M., Simor A., et al. Canadian Nosocomial Infection Surveillance Program. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis 2009, 48:568-576.
13. Beersma M.F., Schutten M., Vennema H., et al. Norovirus in a Dutch tertiary care hospital (2002-2007): frequent nosocomial transmission and dominance of GIIb strains in young children. J Hosp Infect 2009, 71:199-205.
14. Matsuoka D.M., Costa S.F., Mangini C., et al. A nosocomial outbreak of Salmonella enteritidis associated with lyophilized enteral nutrition. J Hosp Infect 2004, 58:122-127.
15. Okii K., Hiyama E., Takesue Y., Kodaira M., Sueda T., Yokoyama T. Molecular epidemiology of enteritis-causing methicillin-resistant Staphylococcus aureus. J Hosp Infect 2006, 62:37-43.
16. Kim J., Smathers S.A., Prasad P., Leckerman K.H., Coffin S., Zaoutis T. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008, 122:1266-1270.
17. Bogdanovič R., Cobeljič M., Markovič M., et al. Haemolytic-uraemic syndrome associated with Aeromonas hydrophila enterocolitis. Pediatr Nephrol 1991, 5:293-335.
18. Friedman C.R., Hoekstra R.M., Samuel M., et al. Emerging Infections Program FoodNet Working Group. Risk factors for sporadic Campylobacter infection in the United States: a case-control study in FoodNet sites. Clin Infect Dis 2004, 38:S285-S296.
19. Yuki N., Kuwabara S. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology. J Peripher Nerv Syst 2007, 12:238-249.
20. Lecuit M., Abachin E., Martin A., et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004, 350:239-248.
21. Sebaihia M., Wren B.W., Mullany P., et al. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 2006, 38:779-786.
22. Voth D.E., Ballard J.D. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005, 18:247-263.
23. Warny M., Pepin J., Fang A., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366:1079-1084.
24. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002, 346:334-339.
25. Stock I., Rahman M., Sherwood K.J., Wiedemann B. Natural antimicrobial susceptibility patterns and biochemical identification of Escherichia albertii and Hafnia alvei strains. Diagn Microbiol Infect Dis 2005, 51:151-163.
26. Rangel J.M., Sparling P.H., Crowe C., Griffin P.M., Swerdlow D.L. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg Infect Dis 2005, 11:603-609.
27. Klein E.J., Stapp J.R., Clausen C.R., et al. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr 2002, 141:172-227.
28. Jones T.F., Ingram L.A., Cieslak P.R., et al. Salmonellosis outcomes differ substantially by serotype. J Infect Dis 2008, 198:109-114.
29. Lan R., Alles M.C., Donohoe K., Martinez M.B., Reeves P.R. Molecular evolutionary relationships of enteroinvasive Escherichia coli and Shigella spp. Infect Immun 2004, 72:5080-51518.
30. Thompson F.L., Iida T., Swings J. Biodiversity of vibrios. Microbiol Mol Biol Rev 2004, 68:403-431.
31. Alam M., Sultana M., Nair G.B., et al. Viable but nonculturable Vibrio cholerae O1 in biofilms in the aquatic environment and their role in cholera transmission. Proc Natl Acad Sci USA 2007, 104:17801-17806.
32. Thompson F.L., Hoste B., Vandemeulebroecke K., Swings J. Reclassification of Vibrio hollisae as Grimontia hollisae gen. nov., comb. nov. Int J Syst Evol Microbiol 2003, 53:1615-1617.
33. Hinestrosa F., Madeira R.G., Bourbeau P.P. Severe gastroenteritis and hypovolemic shock caused by Grimontia ( Vibrio) hollisae infection. J Clin Microbiol 2007, 45:33462-35353.
34. Neubauer H., Aleksic S., Hensel A., Finke E.J., Meyer H. Yersinia enterocolitica 16S rRNA gene types belong to the same genospecies but form three homology groups. Int J Med Microbiol 2000, 290:61-64.
35. Vento S., Cainelli F., Cesario F. Infections and thalassaemia. Lancet Infect Dis 2006, 6:226-233.
36. Nuorti J.P., Niskanen T., Hallanvuo S., et al. A widespread outbreak of Yersinia pseudotuberculosis O:3 infection from iceberg lettuce. J Infect Dis 2004, 189:766-774.
37. Jalava K., Hakkinen M., Valkonen M., et al. An outbreak of gastrointestinal illness and erythema nodosum from grated carrots contaminated with Yersinia pseudotuberculosis. J Infect Dis 2006, 194:1209-1216.
38. Hannu T., Mattila L., Nuorti J.P., et al. Reactive arthritis after an outbreak of Yersinia pseudotuberculosis serotype O:3 infection. Ann Rheum Dis 2003, 62:866-869.
39. Vandenberg O., Dediste A., Houf K., et al. Arcobacter species in humans. Emerg Infect Dis 2004, 10:1863-1867.
40. Snelling W.J., Matsuda M., Moore J.E., Dooley J.S. Under the microscope: Arcobacter. Lett Appl Microbiol 2006, 42:7-14.
41. Hof H. Listeria monocytogenes: a causative agent of gastroenteritis?. Eur J Clin Microbiol Infect Dis 2001, 20:369-373.
42. Ooi S.T., Lorber B. Gastroenteritis due to Listeria monocytogenes. Clin Infect Dis 2005, 40:1327-1332.
43. Hogenauer C., Langner C., Beubler E., et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med 2006, 355:2418-2426.
44. Ni X.P., Ren S.H., Sun J.R., et al. Laribacter hongkongensis isolated from a patient with community-acquired gastroenteritis in Hangzhou City. J Clin Microbiol 2007, 45:255-256.
45. Woo P.C., Lau S.K., Teng J.L., et al. Association of Laribacter hongkongensis in community-acquired gastroenteritis with travel and eating fish: a multicentre case-control study. Lancet 2004, 363:1941-1947.
46. Hofstad T., Olsen I., Eribe E.R., Falsen E., Collins M.D., Lawson P.A. Dysgonomonas gen. nov. to accommodate Dysgonomonas gadei sp. nov., an organism isolated from a human gall bladder, and Dysgonomonas capnocytophagoides (formerly CDC group DF-3). Int J Syst Evol Microbiol 2000, 50(Pt.6):2189-2195.
47. Heiner A.M., DiSario J.A., Carroll K., Cohen S., Evans T.G., Shigeoka A.O. Dysgonic fermenter-3: a bacterium associated with diarrhea in immunocompromised hosts. Am J Gastroenterol 1992, 87:1629-1630.
48. Martinez-Sanchez L., Vasallo E.J., Garcia-Gorrote E., Alcala L., Rodriguez-Créixems M., Bouza E. Clinical isolation of a DF-3 microorganism and review of the literature. Clin Microbiol Infect 1998, 4:344-346.
49. Grob R., Zbinden R., Ruef C., et al. Septicemia caused by dysgonic fermenter 3 in a severely immunocompromised patient and isolation of the same microorganism from a stool specimen. J Clin Microbiol 1999, 37:1617-1618.
50. Giaquinto C., Van Damme P., Huet F., et al. REVEAL Study Group. Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis 2007, 195:S26-S35.
51. Fankhauser R.L., Monroe S.S., Noel J.S., et al. Epidemiologic and molecular trends of 'Norwalk-like viruses' associated with outbreaks of gastroenteritis in the United States. J Infect Dis 2002, 186:1-7.
52. Walter J.E., Mitchell D.K. Astrovirus infection in children. Curr Opin Infect Dis 2003, 16:247-333.
53. Schofield K.P., Morris D.J., Bailey A.S., de Jong J.C., Corbitt G. Gastroenteritis due to adenovirus type 41 in an adult with chronic lymphocytic leukemia. Clin Infect Dis 1994, 19:311-312.
54. Yamashita T., Sugiyama M., Tsuzuki H., Sakae K., Suzuki Y., Miyazaki Y. Application of a reverse transcription-PCR for identification and differentiation of Aichi virus, a new member of the Picornavirus family associated with gastroenteritis in humans. J Clin Microbiol 2000, 38:2955-2961.
55. Chiu C.Y., Greninger A.L., Kanada K., et al. Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections. Proc Natl Acad Sci USA 2008, 105:14124-14129.
56. Bellamy K., Alcock R., Babb J.R., Davies J.G., Ayliffe G.A. A test for the assessment of 'hygienic' hand disinfection using rotavirus. J Hosp Infect 1993, 24:201-210.
57. Kosek M., Bern C., Guerrant R.L. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 2003, 81:197-204s.
58. Luby S.P., Agboatwalla M., Feikin D.R., et al. Effect of handwashing on child health: a randomised controlled trial. Lancet 2005, 366:225-233.
59. Frech S.A., Dupont H.L., Bourgeois A.L., et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet 2008, 371:2019-2025.
60. Dennehy P.H. Rotavirus vaccines: an overview. Clin Microbiol Rev 2008, 21:198-208.
61. Goossens L.M., Standaert B., Hartwig N., Hövels A.M., Al M.J. The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands. Vaccine 2008, 26:1118-1127.
62. Jelinek T., Kollaritsch H. Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera. Expert Rev Vaccines 2008, 7:561-567.
63. Mai N.L., Phan V.B., Vo A.H., et al. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children. N Engl J Med 2003, 349:11390-14141.
64. Marcus L.C., Froeschle J.E., Hill D.R., et al. Safety of Typhim Vi vaccine in a postmarketing observational study. J Travel Med 2007, 14:386-391.
65. Taylor B.V., Williamson J., Luck J., Coleman D., Jones D., McGregor A. Sensitivity and specificity of serology in determining recent acute Campylobacter infection. Intern Med J 2004, 34:250-258.
66. Thomson R.B. Specimen collection, transport, and processing: bacteriology. Manual of clinical microbiology 2007, 291-333. American Society for Microbiology, Washington, DC. 9th ed. P.R. Murray, E.J. Baron, J.H. Jorgensen, M.L. Landry, M.A. Pfaller (Eds.).
67. Valenstein P., Pfaller M., Yungbluth M. The use and abuse of routine stool microbiology: a College of American Pathologists Q-probes study of 601 institutions. Arch Pathol Lab Med 1996, 120:206-211.
68. Klein E.J., Stapp J.R., Clausen C.R., et al. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr 2002, 141:172-227.
69. Dediste A., Vandenberg O., Vlaes L., et al. Evaluation of the ProSpecT Microplate Assay for detection of Campylobacter: a routine laboratory perspective. Clin Microbiol Infect 2003, 9:1085-1090.
70. Nato F., Phalipon A., Nguyen T.L., Diep T.T., Sansonetti P., Germani Y. Dipstick for rapid diagnosis of Shigella flexneri 2a in stool. PLoS ONE 2007, 2:e361.
71. Dieckmann R., Helmuth R., Erhard M., Malorny B. Rapid classification and identification of salmonellae at the species and subspecies levels by whole-cell matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl Environ Microbiol 2008, 74:7767-7778.
72. Wang H., Murdoch D.R. Detection of Campylobacter species in faecal samples by direct Gram stain microscopy. Pathology 2004, 36:343-344.
73. Turgeon D.K., Fritsche T.R. Laboratory approaches to infectious diarrhea. Gastroenterol Clin North Am 2001, 30:693-707.
74. Von Graevenitz A. The role of Aeromonas in diarrhea: a review. Infection 2007, 35:59-64.
75. Wilkes J.G., Rushing L.G., Gagnon J.F., et al. Rapid phenotypic characterization of Vibrio isolates by pyrolysis metastable atom bombardment mass spectrometry. Antonie Van Leeuwenhoek 2005, 88:151-161.
76. Hartling L., Bellemare S., Wiebe N., Russell K., Klassen T.P., Craig W. Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children. Cochrane Database Syst Rev. 2006, (3). CD004390.
77. De Bruyn G., Hahn S., Borwick A. Antibiotic treatment for travellers' diarrhoea. Cochrane Database Syst Rev 2000, (3). CD002242.
78. Al-Abri S., Beeching N., Nye F. Traveller's diarrhoea. Lancet Infect Dis 2005, 5:349-360.
79. Capilla S., Ruiz J., Goñi P., et al. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates. J Antimicrob Chemother 2004, 53:1068-1071.
80. Tribble D.R., Sanders J.W., Pang L.W., et al. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. Clin Infect Dis 2007, 44:338-346.
81. Rutala W.A. Disinfection and sterilization of patient-care items. Infect Control Hosp Epidemiol 1996, 17:377-384.
82. Zerr D.M., Allpress A.L., Heath J., Bornemann R., Bennett E. Decreasing hospital-associated rotavirus infection: a multidisciplinary hand hygiene campaign in a children's hospital. Pediatr Infect Dis J 2005, 24:397-403.
83. O'Horo J., Safdar N. The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review. Int J Infect Dis 2009, 13(6):663-667.